≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Congenital deformities of hip

DOID EFO Endpoint Browser PheWeb

Q17_CONGEN_DEFORMITI_HIP

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — Q65
  • Cause of death: ICD-10 — Q65

2 out of 7 registries used, show all original rules.

707

4. Check minimum number of events

None

707

5. Include endpoints

None

707

6. Filter based on genotype QC (FinnGen only)

707

Control definitions (FinnGen only)

Control exclude
Q17_CONGEN_MALFO_DEFORMAT_MUSCULOS_SYSTEM

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
Q6[5-9]|Q7
Name in latin
Deformitates congenitae coxae

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 17520 12354 5155
Only index persons 11084 7907 3177
Unadjusted period prevalence (%)
Whole population 0.29 0.35 0.14
Only index persons 0.24 0.29 0.12
Median age at first event (years)
Whole population 0.08 0.05 0.06
Only index persons 0.13 0.10 0.18

-FinnGen-

Key figures

All Female Male
Number of individuals 707 574 133
Unadjusted period prevalence (%) 0.17 0.20 0.06
Median age at first event (years) 24.65 26.48 16.75

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
633
Matched controls
6330
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q65.0
ICD-10 Finland
Congenital dislocation of hip, unilateral
+∞
257.4
229
*
M16.3
ICD-10 Finland
Other dysplastic coxarthrosis
292.3
120.4
119
5
Q65.1
ICD-10 Finland
Congenital dislocation of hip, bilateral
+∞
109.6
102
*
Q65.80
ICD-10 Finland
Congenital dysplastic hip or acetabulum, unilateral
+∞
101.9
95
*
Q65.88
ICD-10 Finland
Other congenital deformities of hip
+∞
98.6
92
*
NF1AA
NOMESCO Finland
Hip X-ray examination
15.2
92.3
161
139
NEK20
NOMESCO Finland
Fenestration or forage of bone of pelvis
+∞
90.9
85
*
Q65.81
ICD-10 Finland
Congenital dysplastic hip or acetabulum, bilateral
+∞
86.5
81
*
L13
ICPC
Hip symptom/complaint
6.5
61.5
182
372
M16.7
ICD-10 Finland
Other secondary coxarthrosis
165.3
58.0
60
*
M16.1
ICD-10 Finland
Other primary coxarthrosis
9.8
56.0
120
148
NE1AA
NOMESCO Finland
Pelvis X-ray examination
10.4
54.8
113
130
NFF25
NOMESCO Finland
Cleaning of hip joint, arthroscopic
82.4
54.1
60
8
NFB60
NOMESCO Finland
Demanding prosthetic replacement of hip
289.0
53.0
53
*
Q65.3
ICD-10 Finland
Congenital subluxation of hip, unilateral
+∞
52.9
50
*
M16.2
ICD-10 Finland
Coxarthrosis resulting from dysplasia, bilateral
+∞
52.9
50
*
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
23.2
52.4
76
37
NFB30
NOMESCO Finland
Primary total prosthetic replacement of hip joint not using cement
13.4
50.8
91
78
NFG00
NOMESCO Finland
Arthroplasty of hip joint
+∞
48.6
46
*
7543A
ICD-9 Finland
Certain congenital musculoskeletal deformities, Congenital dislocation of hip[LUXATIO COXAE CONGENITA]
492.3
46.9
46
*
NFE15
NOMESCO Finland
Plastic repair of capsule or ligament of hip joint
161.1
43.4
45
*
Q65.6
ICD-10 Finland
Unstable hip
+∞
40.0
38
*
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
13.2
39.1
70
59
M16.0
ICD-10 Finland
Primary coxarthrosis, bilateral
11.5
37.1
71
69
NF1DA
NOMESCO Finland
X-ray of hips
17.6
34.9
55
34
75560
ICD-8 Finland
Other congenital anomalies of limbs, Dislocatio congenita coxae (fixata)
339.9
32.2
32
*
NFL22
NOMESCO Finland
Myotomy or tenotomy of hip or thigh
316.8
30.1
30
*
Q65.2
ICD-10 Finland
Congenital dislocation of hip, unspecified
+∞
28.3
27
*
NJ3NA
NOMESCO Finland
Measurement of difference in extremity lengty with X-ray
30.1
27.9
37
13
NEK99
NOMESCO Finland
Other operation on bone of pelvis
+∞
25.2
24
*
NFC20
NOMESCO Finland
Secondary implantation of hip prosthesis
25.6
24.6
34
14
M16.6
ICD-10 Finland
Other secondary coxarthrosis, bilateral
249.0
23.8
24
*
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
11.2
23.2
44
42
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
9.5
22.7
47
53
9294
FHL
Endoprosthesis replacement of the entire hip joint (eg Charnley)
46.9
22.5
27
6
ZXA00
NOMESCO Finland
Right side
2.8
22.2
165
701
B01AB05
ATC
enoxaparin; parenteral
2.8
21.9
170
739
NE1BA
NOMESCO Finland
Pelvis extensive X-ray examination
24.1
21.4
30
13
ZXA05
NOMESCO Finland
Left side
2.9
21.3
148
600
NFC00
NOMESCO Finland
Exchange of a loose part of prosthesis in hip joint
+∞
20.9
20
*
Q65.9
ICD-10 Finland
Congenital deformity of hip, unspecified
+∞
20.9
20
*
WX130
NOMESCO Finland
Interpleural anesthesia
+∞
20.9
20
*
NFC40
NOMESCO Finland
Repair of hip prosthesis by bone transplant to acetabulum
113.8
20.7
22
*
N02AX02
ATC
tramadol; systemic, rectal
2.4
20.5
222
1156
N03AX16
ATC
pregabalin; oral
2.9
20.5
143
578
75561
ICD-8 Finland
Other congenital anomalies of limbs, Praeluxatio congenita coxae (non fixata, fenomeno Ortolani positivo)
+∞
18.8
18
*
NFK30
NOMESCO Finland
Angulation, rotation or displacement osteotomy of femur
72.1
18.8
21
*
M16.9
ICD-10 Finland
Coxarthrosis, unspecified
9.0
18.4
39
46
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
8.4
17.3
38
48
NFU20
NOMESCO Finland
Removal of internal fixation device from femur
13.8
17.1
29
22
L28
ICPC
Limited function/disability (L)
3.1
15.7
94
341
B01AF01
ATC
rivaroxaban; oral
4.2
14.9
58
149
9402
FHL
Plastering in the operating room and possible repositioning
+∞
14.6
14
*
7152E
ICD-9 Finland
Osteo-arthrosis and allied disorders, Osteo-arthrosis, localised, secondary[OSTEORTHROSIS SECUNDARIA,LONKKANIVEL]
82.0
14.6
16
*
ZXE10
NOMESCO Finland
More than one and less than three hours
2.1
14.3
215
1262
NF2AT
NOMESCO Finland
Injection to hip joint with ultrasound guidance
20.6
13.9
20
10
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
14.0
13.8
23
17
XX2AT
NOMESCO Finland
Other injection with ultrasound examination
14.0
13.8
23
17
M25.5
ICD-10 Finland
Pain in joint
2.1
13.8
192
1085
Q66.0
ICD-10 Finland
Talipes equinovarus
+∞
13.6
13
*
Q65.82
ICD-10 Finland
Congenital anterversion of the collum femoris
+∞
13.6
13
*
NF1BA
NOMESCO Finland
Hip extensive X-ray examination
9.7
13.6
27
29
M01AH05
ATC
etoricoxib; oral
1.9
13.5
298
2011
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.1
12.8
179
1012
M24.8
ICD-10 Finland
Other specific joint derangements, not elsewhere classified
15.8
12.7
20
13
M91.2
ICD-10 Finland
Coxa plana
+∞
12.5
12
*
NFA30
NOMESCO Finland
Exploration of hip joint, arthroscopic
132.5
12.5
13
*
B01AX06
ATC
[U] rivaroxaban; oral
8.2
11.9
26
33
Z96.6
ICD-10 Finland
Presence of orthopaedic joint implants
6.9
11.9
29
44
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.5
11.7
55
168
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.6
11.6
93
400
Q65.4
ICD-10 Finland
Congenital subluxation of hip, bilateral
+∞
11.5
11
*
NEU20
NOMESCO Finland
Removal of internal fixation device from pelvis
+∞
11.5
11
*
Q65.5
ICD-10 Finland
Congenital subluxation of hip, unspecified
+∞
11.5
11
*
M76.1
ICD-10 Finland
Psoas tendinitis
122.1
11.5
12
*
R4110
NOMESCO Finland
Physiotherapy
2.0
11.2
161
913
71300
ICD-8 Finland
Osteo-arthritis and allied conditions, Arthritis (arthrosis) coxae
44.1
11.0
13
*
M01AH01
ATC
celecoxib; oral (coxibs)
2.5
10.9
92
406
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.5
10.8
51
156
9165
FHL
Removal of osteosynthesis material
7.8
10.8
24
32
WX320
NOMESCO Finland
Spinalanesthesy
2.2
10.5
113
563
9321
FHL
The first reartroplast due to detachment, also includes the treatment of a fracture due to detachment
111.8
10.4
11
*
Q65.8
ICD-10 Finland
Other congenital deformities of hip
+∞
10.4
10
*
N02AJ06
ATC
codeine and paracetamol; systemic
1.8
10.3
208
1325
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.0
10.0
144
813
L89
ICPC
Osteoarthrosis of hip
7.6
9.8
22
30
ZXE20
NOMESCO Finland
More than three and less than five hours
2.4
9.7
85
385
9964A
ICD-9 Finland
Complications peculiar to certain specified procedures, Mechanical complication of internal orthopaedic device, implant and graft
101.5
9.4
10
*
X59
ICD-10 Finland
Exposure to unspecified factor
2.0
9.4
125
681
M17.1
ICD-10 Finland
Other primary gonarthrosis
2.4
9.1
79
355
NFB40
NOMESCO Finland
Primary total prosthetic replacement of hip joint using hybrid technique
6.7
9.0
22
34
A28
ICPC
Limited function/disability NOS
2.7
8.9
61
242
A02BC05
ATC
esomeprazole; systemic
1.8
8.8
193
1256
SPAT1216
SPAT
Assessment of functional ability
2.4
8.7
76
340
M01AE02
ATC
naproxen; oral, rectal
1.7
8.7
378
2989
S70.0
ICD-10 Finland
Contusion of hip
4.6
8.6
29
66
ZSN00
NOMESCO Finland
Procedure related to previous procedure classified in chapter N
27.9
8.5
11
*
L08
ICPC
Shoulder symptom/complaint
2.2
8.5
95
479
A02BC02
ATC
pantoprazole; systemic
1.7
8.4
288
2126
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.7
8.4
56
216
9403
FHL
Adductorotomy
+∞
8.3
8
*
TNF31
NOMESCO Finland
Prefabricated orthosis, hip or thigh
+∞
8.3
8
*
M15.9
ICD-10 Finland
Polyarthrosis, unspecified
4.0
8.2
31
80
S73.1
ICD-10 Finland
Sprain and strain of hip
9.6
7.8
15
16
Q79.6
ICD-10 Finland
Ehlers-Danlos syndrome
25.3
7.6
10
*
M79.6
ICD-10 Finland
Pain in limb
1.7
7.6
193
1303
M01AB05
ATC
diclofenac; systemic, rectal
1.6
7.4
300
2287
Q65
ICD-10 Finland
Congenital deformities of hip
+∞
7.3
7
*
SPAT1229
SPAT
Assessment of need for aid
3.3
7.3
35
111
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
5.1
7.2
21
42
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.6
6.9
207
1454
N02BE01
ATC
paracetamol; systemic, rectal
1.6
6.8
456
3901
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
3.2
6.6
32
102
WX002
NOMESCO Finland
Sedation and analgesia
1.9
6.6
95
533
NFK99
NOMESCO Finland
Other operation on bone of femur
70.5
6.4
7
*
NE1DG
NOMESCO Finland
Pelvic, hip and femur very extensive MRI examination with high intensity magnet
11.2
6.3
11
10
B01AX05
ATC
fondaparinux; parenteral
18.2
6.3
9
5
Q65.83
ICD-10 Finland
Congenital coxa whale
+∞
6.3
6
*
NFK70
NOMESCO Finland
Bone transport operation of femur
+∞
6.3
6
*
NF1CB
NOMESCO Finland
Hip artrography with X-ray
+∞
6.3
6
*
Q05.2
ICD-10 Finland
Lumbar spina bifida with hydrocephalus
+∞
6.3
6
*
M16
ICD-10 Finland
Coxarthrosis [arthrosis of hip]
4.2
6.3
22
54
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
2.7
6.2
40
154
M05BA04
ATC
alendronic acid; oral
3.0
6.2
33
114
M01AB55
ATC
diclofenac, combinations; oral
3.0
6.1
32
109
M03BX02
ATC
tizanidine; oral
1.5
6.1
283
2196
NK5AT
NOMESCO Finland
Joint injection with ultrasound guidance not elsewhere classified
6.8
6.1
14
21
M22.0
ICD-10 Finland
Recurrent dislocation of patella
4.6
6.0
19
42

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3044640) Blood type and Crossmatch panel - Blood
244
1595
1.81
11.82
3.1
2.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
339
2458
1.73
11.31
4.6
4.0
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
383
2915
1.68
10.34
5.3
5.2
mmol/l
6.1
6.2
0.59
353
2647
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
197
1257
1.78
10.09
3.1
2.4
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
227
1515
1.73
9.91
4.2
5.0
inr
1.0
1.1
0.71
66
475
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
322
2385
1.64
9.33
9.0
8.0
mmol/l
1.2
1.2
1.13
285
2085
(3013707) Erythrocyte sedimentation rate by Westergren method
488
4028
1.68
9.06
4.4
3.8
mm/h
10.3
9.1
1.20
455
3733
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
293
2196
1.57
7.64
8.9
8.3
mmol/l
1.2
1.2
1.02
271
2029
(3014111) Lactate [Moles/volume] in Serum or Plasma
76
400
2.01
6.93
7.6
10.8
mmol/l
1.4
1.3
0.17
70
376
(3024561) Albumin [Mass/volume] in Serum or Plasma
256
1893
1.55
6.92
5.4
5.1
g/l
37.2
37.1
0.13
237
1780
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
311
2402
1.52
6.87
7.6
5.8
umol/l
11.3
13.9
1.50
284
2238
(3003396) Base excess in Arterial blood by calculation
70
362
2.03
6.70
8.6
9.0
mmol/l
0.1
0.9
0.95
58
285
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
203
1444
1.57
6.43
2.6
2.4
u/l
56.1
56.3
0.03
183
1338
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
69
361
2.01
6.40
8.7
9.0
kpa
5.1
5.3
0.62
63
349
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
85
480
1.87
6.31
3.2
3.3
%
32.3
32.7
0.14
64
331
(3023368) Bacteria identified in Blood by Culture
154
1050
1.60
5.79
4.6
3.7
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
22
70
3.21
5.78
3.5
4.1
%
0.7
1.2
0.74
17
53
(3031040) Bacteria [#/volume] in Urine by Automated count
437
3699
1.47
5.72
4.6
4.0
e6/l
277.9
408.3
—
8
47
(3002179) Metamyelocytes/100 leukocytes in Blood
66
361
1.91
5.40
4.4
4.1
%
0.3
0.5
0.63
22
76
(3016502) Oxygen saturation in Arterial blood
60
323
1.94
5.16
9.3
9.5
%
96.1
95.5
0.18
54
312
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
97
605
1.70
5.15
3.2
2.5
%
23.7
22.3
0.33
88
537
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
437
3743
1.44
5.07
8.4
6.0
u/l
81.9
84.7
0.57
420
3517
(3021440) Promyelocytes/100 leukocytes in Blood
67
377
1.86
5.04
5.1
4.7
%
0.0
0.1
0.68
29
103
(3013512) EKG study
153
1073
1.54
5.03
3.1
3.0
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
598
5458
1.62
5.03
15.5
11.4
mmol/l
139.5
139.6
0.41
586
5296
(3003458) Phosphate [Moles/volume] in Serum or Plasma
111
724
1.63
4.97
9.8
8.1
mmol/l
1.2
1.2
0.62
103
683
(3019225) pH of Specimen
66
372
1.85
4.94
4.6
4.0
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
446
3845
1.43
4.92
4.6
3.9
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
29
120
2.48
4.77
2.7
2.2
ug/l
258.4
192.7
0.35
23
106
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
62
348
1.86
4.71
6.1
5.6
ng/l
61.5
61.5
0.00
56
324
(3023103) Potassium [Moles/volume] in Serum or Plasma
597
5469
1.58
4.69
15.6
11.4
mmol/l
3.9
3.9
0.69
583
5287
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
27
109
2.53
4.67
4.6
4.3
%
1.5
1.7
0.34
22
100
(3022948) Iron [Moles/volume] in Serum or Plasma
111
737
1.60
4.61
3.0
2.4
umol/l
13.9
14.1
0.08
101
684
(3017181) Myelocytes/100 leukocytes in Blood
68
398
1.78
4.52
5.0
4.6
%
0.4
0.7
0.83
30
114
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
27
111
2.49
4.51
1.3
1.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
628
5843
1.66
4.39
14.6
10.5
mg/l
18.8
20.6
0.90
494
4329
(42870588) Differential panel, method unspecified - Blood
261
2079
1.40
4.38
7.8
6.7
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
38
185
2.11
4.32
12.6
13.3
mmol/l
22.8
24.1
1.30
38
180
(3022096) Basophils/100 leukocytes in Blood
335
2792
1.38
4.25
7.7
6.7
%
0.6
0.6
0.06
310
2639
(3002030) Lymphocytes/100 leukocytes in Blood
361
3047
1.38
4.22
7.5
6.5
%
31.8
32.1
0.15
331
2892
(3025159) Blasts/100 leukocytes in Blood
62
361
1.79
4.20
5.2
4.7
%
0.0
0.1
0.49
23
86
(3017354) Segmented neutrophils/100 leukocytes in Blood
14
41
3.46
4.20
3.4
3.6
%
59.9
53.7
—
9
23
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
119
821
1.54
4.18
3.8
4.0
ng/l
833.8
956.6
0.22
97
675
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
185
1405
1.43
4.01
2.4
2.4
mg/l
2.7
2.8
0.31
161
1215
(3004789) Transferrin [Mass/volume] in Serum or Plasma
101
678
1.57
4.00
3.1
2.3
g/l
2.5
2.5
0.24
93
628
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
513
4609
1.41
3.97
11.1
8.5
ml/min/173m2
98.2
95.8
1.32
423
3502
(3014576) Chloride [Moles/volume] in Serum or Plasma
75
469
1.67
3.96
6.2
7.7
mmol/l
106.2
105.0
1.69
75
462
(3020779) Urea [Moles/volume] in Serum or Plasma
72
446
1.68
3.94
10.1
10.3
mmol/l
6.4
6.1
0.19
66
432
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
514
4626
1.40
3.89
4.5
3.9
pmol/l
14.5
14.4
0.49
470
4214
(3022145) Colonoscopy Study observation
77
491
1.64
3.78
1.3
1.3
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
279
2290
1.36
3.76
3.1
2.5
nmol/l
74.1
72.4
0.48
251
2107
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
36
182
2.03
3.74
10.6
12.2
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
342
2898
1.35
3.74
7.7
6.6
%
3.2
2.8
1.55
316
2731
(3019069) Monocytes/100 leukocytes in Blood
344
2918
1.35
3.73
7.8
6.8
%
8.1
8.1
0.07
319
2771
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
178
1365
1.41
3.62
2.9
2.9
ng/l
120.2
23.5
0.49
84
656
(3019309) Folate [Moles/volume] in Red Blood Cells
92
619
1.56
3.62
1.6
1.6
nmol/l
1006.6
1146.8
0.85
68
479
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
7
9
7.84
3.56
1.0
1.3
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
351
3003
1.33
3.52
7.3
6.3
%
53.2
53.7
0.32
326
2856
(3026782) Osmolality of Urine
138
1019
1.44
3.45
2.8
2.7
mosm/kgh2o
544.3
557.3
0.26
122
878
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
51
298
1.77
3.45
1.8
1.6
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
394
3435
1.33
3.44
9.9
8.7
e9/l
3.9
3.8
0.22
340
2966
(3000991) Gas panel - Venous blood
85
569
1.56
3.42
11.0
10.9
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
18
70
2.61
3.40
1.7
1.3
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
118
849
1.47
3.38
1.4
1.4
titre
680.0
642.3
0.06
24
158
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
20
83
2.45
3.32
1.4
1.5
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
195
1538
1.37
3.32
3.6
2.7
mmol/l
2.4
2.4
1.59
171
1380
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
158
1207
1.40
3.26
2.7
2.1
u/l
210.2
229.6
0.11
144
1146
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
18
72
2.54
3.23
1.7
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
18
72
2.54
3.23
1.7
1.3
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
8
15
5.38
3.19
1.1
2.0
ug/l
137.9
132.4
—
8
15
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
41
230
1.83
3.18
2.1
1.7
—
—
—
0
0
(3022313) Gas panel - Capillary blood
74
492
1.56
3.08
8.3
10.3
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
127
944
1.42
3.06
1.4
1.4
nmol/l
19.7
20.5
0.25
108
816
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
30
154
1.99
3.03
1.4
1.2
u/ml
2.1
11.6
—
5
27
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
84
578
1.51
3.00
8.3
10.1
mmol/l
1.2
1.1
0.11
65
409
(3012095) Magnesium [Moles/volume] in Serum or Plasma
103
740
1.46
2.98
6.6
6.5
mmol/l
0.8
0.8
0.17
98
698
(3017143) Hepatitis C virus Ab [Presence] in Serum
127
949
1.41
2.97
1.7
1.6
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
140
1064
1.39
2.97
2.4
2.5
ug/g
99.0
94.2
0.07
107
823
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
206
1664
1.33
2.96
1.8
1.7
pmol/l
99.6
97.7
0.23
109
866
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
17
70
2.46
2.89
1.7
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
17
71
2.43
2.81
1.7
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
17
71
2.43
2.81
1.7
1.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
124
934
1.40
2.77
1.3
1.2
u/ml
24.6
9.1
0.68
41
351
(3016018) Differential panel - Cerebral spinal fluid
18
78
2.34
2.76
3.6
2.6
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
31
167
1.89
2.75
1.4
1.2
—
19.8
—
0
12
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
116
865
1.41
2.74
3.4
2.9
e6/l
3.5
3.9
0.18
60
469
(40761511) CBC panel - Blood by Automated count
638
6072
1.51
2.73
13.4
9.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
58
376
1.59
2.71
2.2
1.8
e9/l
4.2
4.2
0.04
47
325
(3013115) Eosinophils [#/volume] in Blood
359
3155
1.28
2.68
7.7
7.0
e9/l
0.2
0.2
1.83
311
2776
(3042936) Bacteria identified in Isolate by Culture
90
644
1.45
2.66
2.1
1.9
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
209
1719
1.31
2.60
3.6
3.3
u/l
33.4
30.4
0.25
199
1650
(3002032) Base excess in Venous blood by calculation
87
624
1.45
2.55
6.8
7.9
mmol/l
1.0
1.3
0.44
75
478
(3026008) Bacteria identified in Urine by Culture
200
1641
1.30
2.53
3.3
2.4
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
17
75
2.30
2.52
1.2
1.3
—
68.5
—
0
6
(3005719) IgG [Mass/volume] in Serum or Plasma
70
482
1.50
2.51
3.1
3.1
g/l
9.9
9.3
0.62
65
446
(3030467) Casts [#/volume] in Urine by Automated count
181
1466
1.31
2.51
3.4
3.2
e6/l
0.4
0.3
0.14
132
1088
(3021589) Normoblasts [#/volume] in Blood
318
2771
1.27
2.49
10.1
8.6
e9/l
0.0
0.0
0.40
258
2205
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
566
5298
1.34
2.48
5.1
4.5
mu/l
1.9
2.1
0.44
528
4960
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
216
1797
1.29
2.45
4.1
3.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
71
494
1.48
2.43
1.5
1.6
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
6
12
5.03
2.40
3.8
2.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
215
1792
1.29
2.40
1.6
1.5
g/l
1.8
1.8
0.11
130
1034
(3019060) Gas panel - Arterial blood
31
176
1.79
2.37
3.6
3.6
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
32
184
1.77
2.35
2.9
2.0
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
143
1137
1.32
2.25
2.3
2.5
mg/l
1.4
1.1
0.26
103
820
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
94
704
1.39
2.18
2.3
1.9
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
8
24
3.36
2.18
1.3
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
8
24
3.36
2.18
1.3
1.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
115
891
1.35
2.16
3.2
2.8
e6/l
1.1
1.1
0.05
61
492
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
441
4033
1.25
2.13
4.2
4.2
mmol/mol
36.9
37.7
0.95
412
3793
(3044290) Cell count panel - Cerebral spinal fluid
26
145
1.82
2.13
3.1
3.0
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
19
95
2.03
2.12
1.2
1.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
121
949
1.33
2.10
1.3
1.3
iu/ml
39.6
26.7
0.27
36
282
(3023323) Follitropin [Units/volume] in Serum or Plasma
62
434
1.47
2.09
1.8
1.7
iu/l
22.9
20.7
0.21
52
337
(3004616) Nuclear Ab [Presence] in Serum
14
62
2.28
2.08
1.6
1.3
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
353
3158
1.23
2.06
7.6
6.5
e9/l
2.1
2.2
0.70
315
2799
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
234
2002
1.25
2.06
1.5
1.5
u/ml
1.3
2.6
1.05
59
477
(3009261) Glucose [Presence] in Urine by Test strip
317
2805
1.23
2.05
3.7
3.2
estimate
0.0
0.0
0.00
73
541
(3003694) ABO and Rh group [Type] in Blood
229
1956
1.25
2.04
1.6
1.7
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
6
15
4.02
2.04
1.0
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
22
118
1.89
2.03
1.7
1.3
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
341
3043
1.23
2.03
7.6
6.6
e9/l
0.0
0.0
0.43
295
2636
(4035726)
51
345
1.51
2.03
1.3
1.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
29
170
1.73
2.03
2.3
1.9
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
192
1608
1.27
2.02
3.8
3.3
e6/l
25.5
49.4
0.87
148
1216
(3001604) Monocytes [#/volume] in Blood
339
3032
1.23
1.95
7.6
6.5
e9/l
0.6
0.5
0.06
294
2625
(3029396) Erythrocyte agglutination [Presence] in Blood
8
27
2.98
1.94
1.9
3.5
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
68
493
1.42
1.92
6.6
8.1
mmol/l
23.7
23.6
0.14
68
464
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
13
58
2.26
1.91
1.4
1.2
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
313
2781
1.22
1.91
5.3
4.5
estimate
0.0
0.0
0.00
73
561
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
0
51
0.00
1.89
0.0
1.1
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
27
159
1.72
1.87
1.4
1.5
nmol/l
0.3
0.3
0.10
27
132
(3006922) Hepatitis E virus Ab [Presence] in Serum
8
28
2.88
1.86
1.3
1.1
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
133
1077
1.29
1.83
2.7
2.8
e6/l
9.7
8.7
0.23
116
946
(36660697) Celiac disease serology panel - Serum
95
734
1.34
1.83
1.3
1.2
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
338
3038
1.21
1.81
3.4
2.9
ug/l
84.5
60.8
2.06
319
2853
(3001964) Herpes simplex virus Ag [Presence] in Specimen
7
23
3.06
1.80
1.3
3.1
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
7
23
3.06
1.80
1.3
1.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
176
1479
1.25
1.79
3.5
3.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
16
81
2.00
1.75
6.2
3.4
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
20
110
1.84
1.74
3.4
1.7
ug/l
0.6
3.9
0.74
14
102
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
389
3554
1.21
1.73
3.6
3.1
u/l
35.1
32.6
0.31
372
3391
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
90
699
1.33
1.69
3.2
2.3
mmol/l
2.4
2.4
0.43
79
608
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
495
4636
1.22
1.68
3.6
3.3
mmol/l
5.6
5.6
0.00
449
4278
(3035350) Ketones [Presence] in Urine by Test strip
310
2778
1.21
1.67
3.8
3.2
estimate
0.0
0.0
0.00
71
537
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
13
62
2.12
1.66
1.1
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
13
63
2.08
1.60
1.1
1.1
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
6
20
3.01
1.58
1.8
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
6
20
3.01
1.58
1.8
1.3
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
50
358
1.43
1.55
15.3
15.4
inr
1.1
1.1
—
9
69
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
8
33
2.44
1.54
2.5
2.2
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
5
15
3.35
1.52
1.0
3.1
u/l
229.0
223.9
—
5
15
(3045424) Erythrocytes [Presence] in Urine
16
86
1.88
1.51
1.7
1.4
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
16
86
1.88
1.51
2.1
2.8
e6/l
837.5
508.7
1.51
11
65
(3008757) Leukocyte morphology finding [Identifier] in Blood
14
72
1.96
1.49
4.3
5.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
73
935
0.75
1.49
4.1
4.1
mg/mmol
5.0
29.4
0.71
48
598
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
38
261
1.48
1.46
1.2
1.3
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
9
38
2.38
1.46
3.2
1.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
192
1664
1.21
1.44
2.6
2.4
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
5
16
3.14
1.44
1.4
6.5
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
70
538
1.33
1.43
7.0
4.7
%
1.6
1.6
0.12
63
490
(3007853) Bacteria identified in Skin by Aerobe culture
86
683
1.29
1.40
1.7
1.6
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
14
74
1.91
1.39
1.4
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
35
239
1.49
1.39
1.5
1.7
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
33
223
1.50
1.38
1.8
1.6
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
21
127
1.67
1.37
1.3
1.5
u/l
30.5
17.3
0.68
16
109
(3037121) Protein [Mass/volume] in Urine
32
215
1.51
1.37
5.9
5.3
g/l
0.3
0.4
0.44
16
122
(3000330) Specific gravity of Urine by Test strip
31
207
1.52
1.37
3.7
2.5
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
17
2.95
1.36
2.0
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
17
2.95
1.36
2.0
1.3
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
5
17
2.95
1.36
1.6
1.3
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
52
385
1.38
1.35
3.8
3.1
pmol/l
4.9
4.8
0.36
46
337
(3011412) CD3 cells [#/volume] in Blood
16
90
1.79
1.33
2.6
2.9
e9/l
1.6
1.5
—
8
55
(1761482) Bacteria [#/volume] in Urine by Culture
16
90
1.79
1.33
3.5
3.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
70
887
0.77
1.33
3.5
3.3
mg/l
44.7
146.0
0.68
44
580
(3023520) Reticulocytes [#/volume] in Blood
49
362
1.38
1.30
6.9
3.5
e9/l
75.2
70.8
0.33
37
250
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
8
34
2.37
1.29
1.0
1.6
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
8
34
2.37
1.29
1.0
1.1
iu/ml
114.7
145.3
—
8
34
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
5
18
2.79
1.28
5.8
5.9
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
5
18
2.79
1.28
6.0
6.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
21
327
0.63
1.28
1.5
1.6
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
11
55
2.01
1.27
7.2
1.7
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
224
1990
1.18
1.27
4.4
3.8
e6/l
119.5
80.0
0.38
159
1312
(3000570) Elastase.pancreatic [Mass/mass] in Stool
23
146
1.59
1.27
1.2
1.3
ug/g
328.3
335.5
—
9
77
(3018418) pH of Serum or Plasma
150
1286
1.21
1.26
4.5
3.3
ph
7.4
7.4
0.72
33
231
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
62
479
1.32
1.25
2.1
2.2
u/l
40.3
31.9
0.42
47
391
(3041096) Erythrocytes [Presence] in Urine by Automated
183
1602
1.19
1.23
3.4
2.8
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
40
289
1.41
1.22
1.7
1.6
—
—
—
0
0
(3044889) 12 lead EKG panel
334
3073
1.16
1.22
3.0
2.8
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
595
5739
1.23
1.20
15.3
11.9
%
39.0
39.6
1.36
483
4761
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
6
26
2.32
1.18
3.7
5.7
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
201
1781
1.18
1.17
2.7
2.5
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
10
50
2.01
1.16
1.1
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
10
50
2.01
1.16
1.1
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
10
50
2.01
1.16
1.1
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
10
50
2.01
1.16
1.1
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
10
50
2.01
1.16
1.1
1.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
73
583
1.28
1.16
1.4
1.5
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
72
574
1.28
1.16
1.1
1.1
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
19
118
1.63
1.15
4.0
3.5
mg/l
24.6
22.8
0.12
11
77
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
5
20
2.51
1.15
4.8
1.6
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
5
20
2.51
1.15
4.8
1.6
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
28
399
0.69
1.13
1.3
1.3
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
12
65
1.86
1.13
2.8
1.5
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
90
740
1.25
1.13
3.2
3.2
ng/l
185.1
554.2
1.89
54
439
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
37
268
1.40
1.12
1.2
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
10
51
1.97
1.11
1.1
1.2
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
25
168
1.50
1.11
3.0
2.7
e6/l
51.9
3.8
0.68
15
128
(40758558) Short blood count panel - Blood
175
1540
1.18
1.10
7.3
7.3
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
16
96
1.68
1.10
2.8
3.9
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
14
81
1.74
1.09
1.4
1.2
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
5
21
2.39
1.09
4.8
1.6
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
8
41
1.96
1.09
1.4
1.2
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
26
177
1.49
1.09
1.7
2.8
mg/l
360.1
415.6
0.36
26
169
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
25
169
1.50
1.08
3.1
2.8
e6/l
2530.1
294.1
0.58
17
135
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
235
2122
1.16
1.07
3.9
3.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
42
552
0.75
1.06
1.5
1.5
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
49
377
1.32
1.04
1.2
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
70
566
1.26
1.03
1.6
1.4
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
32
230
1.41
1.03
1.6
1.8
u/ml
242.7
193.0
0.36
19
112
(3008898) HLA-B27 [Presence]
44
334
1.34
1.02
1.1
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
61
486
1.28
1.01
5.2
4.7
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
18
272
0.65
1.00
1.3
1.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
138
1204
1.18
0.97
1.8
1.6
mmol/l
1.3
1.3
0.46
127
1057
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
17
108
1.59
0.97
3.8
13.1
u/ml
0.2
0.3
—
10
70
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
12
69
1.75
0.96
1.1
1.1
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
13
77
1.70
0.95
1.7
1.9
%
13.3
13.2
0.17
13
77
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
23
327
0.69
0.95
1.9
2.0
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
28
200
1.42
0.94
2.0
1.9
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
11
62
1.79
0.94
1.1
1.7
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
15
93
1.63
0.94
1.1
1.0
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
108
925
1.20
0.94
3.3
2.9
umol/l
301.1
5789.6
3.92
92
831
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
6
27
2.23
0.93
1.7
2.2
umol/l
29.4
16.4
—
6
27
(46235355) HIV 1 and 2 tests - Meaningful Use set
216
1958
1.15
0.92
2.0
2.1
—
—
—
0
0
(3024731) MCV [Entitic volume]
674
6626
1.35
0.92
21.2
15.4
fl
88.8
88.8
0.14
666
6536
(40768804) Tissue Pathology biopsy report
207
1872
1.15
0.92
1.7
1.9
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
6
28
2.15
0.91
1.2
1.3
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
6
28
2.15
0.91
4.2
1.5
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
6
28
2.15
0.91
4.2
1.5
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
6
28
2.15
0.91
4.2
1.5
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
6
28
2.15
0.91
4.2
1.5
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
6
28
2.15
0.91
2.5
1.6
—
—
—
0
0
(3035941) MCH [Entitic mass]
674
6627
1.35
0.91
21.2
15.4
pg
29.6
29.6
0.13
666
6538
(3024980) IgG subclass 4 [Mass/volume] in Serum
16
102
1.58
0.91
1.9
1.5
g/l
0.7
0.5
0.42
11
81
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
21
143
1.48
0.90
1.4
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
21
143
1.48
0.90
1.4
1.4
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
674
6628
1.35
0.90
21.3
15.5
e12/l
4.5
4.5
1.82
663
6420
(3001019) Free T4 and TSH panel - Serum or Plasma
43
333
1.31
0.90
1.3
1.6
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
6
29
2.08
0.89
1.2
1.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
27
194
1.41
0.89
2.0
1.8
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
32
237
1.37
0.89
2.2
2.3
ug/l
15.8
5.4
0.62
22
211
(21494434) Karyotype in Bone marrow
8
42
1.91
0.88
1.3
1.2
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
14
87
1.62
0.88
2.1
2.4
%
18.9
16.8
—
8
46
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
8
43
1.87
0.87
4.1
1.6
pg
31.5
31.1
—
8
43
(3037756) Immunofixation for Serum or Plasma
8
43
1.87
0.87
1.3
1.7
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
8
43
1.87
0.87
1.8
2.3
—
—
—
0
0
(40768441) Liver Pathology biopsy report
8
43
1.87
0.87
1.0
1.5
—
—
—
0
0
(3024471) HLA-A [Type]
6
30
2.01
0.87
1.0
1.0
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
22
153
1.45
0.86
1.8
1.8
iu/l
5.2
6.0
—
9
55
(3010813) Leukocytes [#/volume] in Blood
674
6632
1.33
0.86
21.3
15.5
e9/l
6.7
6.8
0.23
662
6419
(3007461) Platelets [#/volume] in Blood
673
6621
1.33
0.85
21.4
15.5
e9/l
262.5
266.7
0.93
660
6427
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
23
162
1.43
0.85
1.2
1.3
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
45
1.79
0.84
1.6
1.2
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
8
45
1.79
0.84
1.8
2.2
mmol/l
105.8
106.1
—
8
45
(3041354) Potassium [Moles/volume] in Venous blood
8
45
1.79
0.84
1.8
2.2
mmol/l
4.0
3.9
—
8
45
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
20
284
0.70
0.84
1.4
1.7
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
72
600
1.22
0.84
1.2
1.2
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
10
57
1.76
0.83
2.6
4.3
—
3.4
—
0
7
(3021788) Differential panel - Synovial fluid
10
57
1.76
0.83
1.3
1.7
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
674
6634
1.33
0.83
21.5
15.7
g/l
132.0
133.5
2.10
666
6547
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
18
121
1.50
0.83
3.1
1.9
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
17
247
0.68
0.81
1.5
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
17
246
0.68
0.79
1.4
1.4
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
15
99
1.53
0.76
1.0
1.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
59
488
1.23
0.75
1.9
1.8
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
35
272
1.30
0.74
1.2
1.2
u/ml
1.8
7.4
3.19
22
180
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
26
193
1.36
0.74
3.7
7.3
%
0.7
0.7
0.17
26
188
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
37
290
1.29
0.73
5.6
3.8
ug/l
2.7
7.0
1.59
28
225
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
598
5831
1.16
0.73
11.3
8.4
u/l
23.9
24.5
0.35
575
5645
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
5
25
2.01
0.72
1.2
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
25
2.01
0.72
1.2
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
25
2.01
0.72
1.2
1.2
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
14
92
1.53
0.72
8.6
5.2
umol/l
439.1
393.3
0.54
14
83
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
54
650
0.82
0.72
1.4
1.5
—
—
—
0
0
(44813793)
11
68
1.63
0.72
1.2
1.0
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
164
1486
1.13
0.71
3.9
3.4
estimate
0.0
0.0
0.80
72
548
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
5
26
1.93
0.70
1.2
1.2
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
5
26
1.93
0.70
1.2
1.2
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
18
251
0.71
0.70
1.4
1.5
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
7
41
1.71
0.70
1.6
1.1
—
83.8
—
0
8
(4281824)
7
41
1.71
0.70
1.0
1.1
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
71
605
1.19
0.68
3.4
4.1
umol/l
5.1
6.5
0.78
56
504
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
5
27
1.86
0.68
1.0
1.1
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
7
42
1.67
0.68
3.7
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
7
42
1.67
0.68
3.7
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
7
42
1.67
0.68
3.7
1.5
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
7
43
1.63
0.67
3.3
5.1
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
5
28
1.79
0.66
1.2
1.5
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
37
295
1.27
0.66
1.2
1.2
u/ml
0.8
2.2
0.93
20
156
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
12
78
1.55
0.65
2.2
3.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
21
154
1.37
0.65
1.1
1.1
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
8
127
0.63
0.64
3.4
3.9
%
46.3
55.1
—
8
127
(3024932) HLA-DR beta [Type]
5
29
1.73
0.64
1.6
1.0
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
65
554
1.19
0.63
1.7
1.9
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
40
324
1.25
0.63
1.5
2.5
ml/min/173m2
92.0
78.4
—
8
126
(21494755) Public health laboratory ask at order entry panel
73
629
1.18
0.63
1.2
1.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
8
49
1.64
0.62
4.3
1.9
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
162
1480
1.12
0.62
1.7
1.7
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
5
30
1.67
0.61
1.0
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
21
156
1.36
0.61
1.0
1.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
8
50
1.61
0.61
1.1
1.1
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
1.2
—
93.4
—
0
14
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
58
492
1.19
0.60
2.1
1.9
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
8
52
1.54
0.59
1.8
4.1
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
58
493
1.19
0.59
2.0
1.9
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
14
97
1.45
0.59
2.6
2.6
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
33
265
1.26
0.57
1.2
1.2
u/ml
0.3
1.5
1.51
19
156
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
6
36
1.67
0.56
1.8
4.0
—
59.5
—
0
8
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
115
1271
0.89
0.56
1.5
1.5
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
35
284
1.24
0.56
3.9
3.8
ug/l
2.2
1.6
0.59
30
253
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
8
55
1.46
0.56
1.1
1.1
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
17
124
1.38
0.56
2.3
3.3
umol/l
36.0
33.5
0.29
12
103
(3011397) Hemoglobin [Presence] in Urine by Test strip
143
1307
1.12
0.55
3.5
3.1
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
8
124
0.64
0.55
2.9
3.7
e9/l
3.4
4.0
—
8
124
(3014051) Protein [Presence] in Urine by Test strip
16
116
1.39
0.54
1.9
1.8
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
9
60
1.51
0.54
1.0
1.0
—
—
—
0
0
(4062490)
11
74
1.49
0.53
2.1
1.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
19
143
1.34
0.52
1.4
1.1
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
19
143
1.34
0.52
2.5
3.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
29
233
1.25
0.51
1.2
1.2
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
18
135
1.34
0.51
4.3
8.8
mmol/l
25.0
23.7
0.60
18
119
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
77
681
1.15
0.50
2.1
2.2
u/l
1682.6
5917.8
1.82
21
244
(3034274) Bile acid [Moles/volume] in Serum --fasting
23
180
1.29
0.50
2.5
3.5
umol/l
7.6
10.6
0.37
17
144
(3015736) pH of Urine
233
2195
1.09
0.49
3.5
3.0
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
21
163
1.30
0.48
1.0
1.1
u/ml
0.1
0.6
1.20
11
55
(3023430) Cat dander IgE Ab [Units/volume] in Serum
22
172
1.29
0.48
1.1
1.1
u/ml
12.7
10.9
0.14
12
78
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
33
272
1.22
0.48
1.3
1.5
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
90
808
1.13
0.47
1.4
1.5
pmol/l
467.6
28249029.8
1.05
77
708
(3023511) Choriogonadotropin [Units/volume] in Urine
44
374
1.19
0.47
1.3
1.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
205
2177
0.92
0.47
1.9
1.9
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
10
68
1.48
0.47
1.0
1.1
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
12
85
1.42
0.47
3.0
3.6
u/ml
478.1
57.2
0.41
12
78
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
7
48
1.46
0.47
2.3
5.0
ug/l
2.4
2.2
—
7
48
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
49
1.43
0.46
1.3
1.2
—
—
—
0
0
(4094501)
5
83
0.60
0.46
1.0
1.1
—
—
—
0
0
(4010399)
39
330
1.19
0.44
1.5
1.4
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
39
331
1.19
0.43
2.2
1.8
u/l
7.1
9.4
0.71
31
239
(3022621) pH of Urine by Test strip
38
322
1.19
0.43
2.8
2.2
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
5
31
1.62
0.43
1.0
1.0
—
15.1
—
0
9
(4027681)
8
56
1.43
0.42
1.3
1.3
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
6
92
0.65
0.42
1.5
1.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
16
122
1.32
0.42
1.3
1.8
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
8
57
1.41
0.42
1.0
1.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
20
158
1.27
0.42
2.1
1.9
—
—
—
0
0
(1616796) Gas panel - Central venous blood
13
96
1.36
0.41
6.9
3.6
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
8
58
1.38
0.41
1.4
1.1
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
17
132
1.29
0.40
1.2
1.2
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
12
88
1.37
0.40
4.8
9.6
%
66.5
65.7
0.04
12
88
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
46
400
1.16
0.39
2.8
2.7
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
8
61
1.31
0.39
1.1
1.1
mg/l
124.0
179.3
—
8
55
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
(3000492) Spirometry study
56
496
1.14
0.38
1.4
1.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
25
206
1.22
0.38
2.1
2.3
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
9
67
1.35
0.38
1.1
1.0
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
12
89
1.35
0.38
1.3
1.3
—
—
—
0
0
(3002256) Pathology report gross observation
61
544
1.13
0.38
1.2
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
166
1761
0.92
0.37
2.3
2.3
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
535
5243
1.08
0.37
18.0
13.3
%
13.5
13.4
1.60
522
5158
(3004588) Protein electrophoresis panel - Serum or Plasma
21
170
1.24
0.37
1.8
2.0
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
121
1300
0.92
0.37
2.0
1.6
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
5
37
1.35
0.37
3.0
2.3
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
6
41
1.47
0.36
1.2
1.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
6
41
1.47
0.36
1.8
4.6
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
12
90
1.34
0.36
1.2
1.0
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
109
1172
0.92
0.34
2.6
2.1
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
6
44
1.37
0.34
1.7
2.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
55
613
0.89
0.34
1.9
1.8
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
6
45
1.34
0.34
1.5
2.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
15
118
1.28
0.33
1.1
1.2
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
30
257
1.17
0.32
2.2
1.8
nmol/l
11.6
9.9
0.33
25
225
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
17
137
1.25
0.32
1.6
1.4
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
30
258
1.17
0.31
1.2
1.1
u/ml
2.1
6.2
—
7
71
(3011648) Oxygen content in Venous blood
7
54
1.30
0.30
7.4
13.2
%
11.5
11.7
—
7
54
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
88
814
1.09
0.30
1.5
1.5
%
1.4
1.4
0.03
79
751
(3019832) Treponema pallidum Ab [Presence] in Serum
134
1262
1.08
0.30
1.7
1.8
—
—
—
0
0
(4034850)
11
141
0.78
0.29
10.1
7.6
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
28
241
1.17
0.29
1.4
1.4
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
16
130
1.24
0.28
1.4
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
21
248
0.84
0.28
1.3
1.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
39
346
1.13
0.28
1.3
1.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
32
281
1.14
0.26
1.5
1.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
149
1416
1.07
0.26
5.7
4.3
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
8
67
1.20
0.26
1.4
1.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
11
86
1.28
0.26
3.8
5.8
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
476
4673
1.05
0.26
3.9
3.7
mmol/l
2.8
2.8
0.66
447
4372
(3009508) Creatinine [Moles/volume] in Urine
130
1369
0.94
0.25
3.5
3.4
mmol/l
8.1
8.0
0.05
118
1197
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
13
105
1.24
0.24
1.2
1.5
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
23
198
1.17
0.24
1.2
1.5
—
10.1
—
0
5
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
23
198
1.17
0.24
1.7
2.1
u/l
43.9
39.4
0.45
23
182
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
31
349
0.88
0.24
1.4
1.5
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
21
180
1.17
0.24
1.9
1.8
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
22
190
1.16
0.23
1.4
1.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
53
575
0.91
0.22
2.1
1.8
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
516
5225
0.95
0.22
3.9
3.9
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
5
41
1.22
0.22
1.2
1.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
13
107
1.22
0.21
4.7
8.8
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
46
421
1.10
0.21
2.4
2.2
—
—
—
0
0
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
5
43
1.16
0.21
2.8
2.1
nmol/l
2.3
2.9
—
5
43
(3005322) IgE [Units/volume] in Serum or Plasma
60
557
1.08
0.21
1.5
1.4
u/ml
334.3
289.8
0.14
52
520
(3020650) Glucose [Presence] in Urine
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
14
0.00
0.20
0.0
2.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
472
4648
1.04
0.20
3.7
3.5
mmol/l
4.7
4.7
0.20
443
4381
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
18
155
1.16
0.20
2.7
2.0
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
21
184
1.14
0.19
1.1
1.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
30
332
0.90
0.19
6.0
3.3
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
16
137
1.17
0.18
1.3
1.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
136
1305
1.05
0.18
3.9
3.2
kg/l
1.0
1.0
0.42
24
199
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
53
1.13
0.18
1.3
1.6
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
6
53
1.13
0.18
1.0
1.4
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
12
100
1.20
0.18
1.5
1.7
mmol/l
7.3
7.1
—
6
59
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
28
252
1.11
0.18
5.5
5.8
g/l
2.8
3.1
0.68
28
243
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
93
976
0.94
0.18
2.3
2.0
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
13
110
1.18
0.17
1.5
2.3
mg/l
10.0
10.0
0.00
13
103
(3035933) Granulocytes/100 leukocytes in Blood
8
68
1.18
0.16
1.3
1.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
21
187
1.13
0.16
1.1
1.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
24
216
1.11
0.15
2.0
1.5
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
9
79
1.14
0.15
1.4
1.5
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
9
80
1.13
0.15
1.7
1.7
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
31
284
1.09
0.15
1.4
1.8
mg/l
4.8
3.5
0.47
20
193
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
13
150
0.86
0.15
1.4
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
8
97
0.82
0.13
1.1
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
8
99
0.81
0.13
1.0
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
59
621
0.94
0.13
2.0
1.8
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
29
314
0.92
0.13
1.4
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
29
314
0.92
0.13
1.4
1.4
—
—
—
0
0
(1002224) Polysomnography panel
16
179
0.89
0.12
1.1
1.1
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
29
313
0.92
0.12
1.3
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
29
313
0.92
0.12
1.3
1.4
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
12
137
0.87
0.12
1.2
1.1
u/ml
1.2
5.0
—
5
57
(42529406) Shigella sp [Presence] in Stool by Culture
21
191
1.10
0.11
1.1
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
59
618
0.95
0.11
2.0
1.8
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
59
616
0.95
0.10
2.0
1.8
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
45
427
1.06
0.10
1.4
1.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
31
290
1.07
0.10
2.1
2.0
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
24
222
1.08
0.10
1.4
1.7
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
5
45
1.11
0.10
2.0
1.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
13
116
1.12
0.09
2.5
1.9
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
444
4400
1.02
0.09
3.4
3.2
mmol/l
1.2
1.2
0.43
410
4122
(3003740) Influenza virus B Ag [Presence] in Specimen
15
165
0.91
0.09
1.2
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
15
165
0.91
0.09
1.2
1.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
6
58
1.03
0.08
2.3
1.4
—
—
—
0
0
(3003338) MCHC [Mass/volume]
541
5437
0.98
0.08
17.0
13.5
g/l
333.1
332.9
0.18
534
5389
(1001926) Buprenorphine [Presence] in Urine by Screen method
51
489
1.05
0.08
2.0
1.7
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
5
60
0.83
0.08
1.2
1.7
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
7
66
1.06
0.08
1.1
1.3
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
6
70
0.86
0.07
1.3
1.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
49
509
0.96
0.07
4.5
3.5
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
80
0.87
0.07
1.4
1.6
—
—
—
0
0
(4306422)
7
83
0.84
0.07
1.1
1.2
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
21
196
1.07
0.07
1.1
1.1
u/ml
16.2
9.5
0.41
11
82
(40768793) Breast Pathology biopsy report
14
128
1.09
0.06
1.1
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
18
192
0.94
0.05
1.2
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
60
585
1.03
0.04
1.3
1.3
iu/ml
169.4
150.8
0.12
18
224
(44790049)
11
101
1.09
0.04
1.4
2.0
—
—
—
0
0
(44790047)
11
101
1.09
0.04
1.4
2.0
—
—
—
0
0
(44806118)
11
101
1.09
0.04
1.4
2.0
—
—
—
0
0
(44790048)
11
101
1.09
0.04
1.4
2.0
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
24
230
1.04
0.03
4.8
3.3
%
20.6
22.9
0.36
12
88
(3006598) pH of Arterial cord blood
10
108
0.92
0.03
1.0
1.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
10
108
0.92
0.03
1.2
1.9
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
11
118
0.93
0.03
1.9
1.4
u/ml
23.0
4.4
—
6
68
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
13
138
0.94
0.02
1.4
1.5
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
25
242
1.03
0.02
1.6
1.5
g/l
1.1
1.2
0.32
25
227
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
10
93
1.08
0.02
1.3
1.9
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
462
4608
1.01
0.01
3.7
3.4
mmol/l
1.5
1.5
0.24
432
4323
(3025018) Bordetella pertussis Ab [Titer] in Serum
10
94
1.06
0.00
1.2
1.2
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
14
134
1.04
0.00
14.2
7.1
iu/ml
493.0
357.9
—
5
17
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
24
234
1.03
0.00
1.7
1.5
g/l
0.2
0.2
0.46
24
222
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
12
123
0.97
0.00
1.3
1.2
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
36
364
0.99
0.00
1.5
1.3
miu/ml
338.8
258.4
0.52
18
182
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
10
101
0.99
0.00
1.2
1.8
—
—
—
0
0
(3020891) Body temperature
13
132
0.98
0.00
4.2
5.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
54
545
0.99
0.00
1.2
1.3
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
10
96
1.04
0.00
2.7
3.1
mmol/l
3.7
3.8
—
10
86
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
10
96
1.04
0.00
1.2
1.2
u/ml
2.0
3.2
—
5
39
(3040151) Glucose [Moles/volume] in Capillary blood
7
69
1.01
0.00
2.4
8.2
mmol/l
5.4
6.3
—
7
56
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7
69
1.01
0.00
3.9
1.7
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
6
61
0.98
0.00
1.5
3.9
umol/l
26.0
27.6
—
6
61
(3019174) dRVVT (LA screen)
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
5
49
1.02
0.00
1.2
1.7
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
5
51
0.98
0.00
1.2
1.3
u/ml
7.5
8.2
—
5
41
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
8
84
0.95
0.00
1.8
2.5
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
5
0.00
0.00
0.0
3.8
—
—
—
0
0
(44806420)
0
7
0.00
0.00
0.0
2.7
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
6
59
1.02
0.00
1.0
1.3
—
—
—
0
0
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
8
0.00
0.00
0.0
2.9
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
7
73
0.96
0.00
1.7
1.5
—
—
—
0
0
(3012898) Urea [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.5
—
257.0
—
0
6
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
5
0.00
0.00
0.0
13.4
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011841) English Walnut IgE Ab [Units/volume] in Serum
5
54
0.92
0.00
1.2
1.2
u/ml
11.9
14.5
—
5
44
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
213.7
—
0
7
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
5
0.00
0.00
0.0
3.0
—
0.6
—
0
5
(3028717) Thiamine [Mass/volume] in Blood
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
8
0.00
0.00
0.0
3.5
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
6
63
0.95
0.00
1.5
1.4
—
—
—
0
0
(3007542) Rye IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
6
64
0.94
0.00
1.0
1.4
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(4198724)
6
63
0.95
0.00
2.7
1.7
—
—
—
0
0
(4133840)
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
8
84
0.95
0.00
2.3
2.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
9
97
0.93
0.00
1.9
1.8
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
9
90
1.00
0.00
3.3
1.5
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
6
67
0.89
0.00
1.0
1.3
nmol/l
0.3
0.5
—
6
62
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.3
—
1.7
—
0
7
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(4268621)
6
64
0.94
0.00
2.3
2.1
—
—
—
0
0
(3005593) Pancreatic islet cell Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.5
—
24.2
—
0
6
(3013166) Neutrophils/100 leukocytes in Synovial fluid
0
5
0.00
0.00
0.0
1.4
—
48.3
—
0
5
(3016330) Potassium [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint Q17_CONGEN_DEFORMITI_HIP and mortality.

Females

Parameter HR [95% CI] p-value
Q17_CONGEN_DEFORMITI_HIP 1.38 [1.15, 1.65] < 0.001
Birth year 0.992 [0.98, 1.0] 0.083

During the follow-up period (1.1.1998 — 31.12.2019), 242 out of 11663 females with Q17_CONGEN_DEFORMITI_HIP died.

Males

Parameter HR [95% CI] p-value
Q17_CONGEN_DEFORMITI_HIP 1.696 [1.33, 2.16] < 0.001
Birth year 0.992 [0.98, 1.0] 0.15

During the follow-up period (1.1.1998 — 31.12.2019), 117 out of 4808 males with Q17_CONGEN_DEFORMITI_HIP died.

Mortality risk

Mortality risk for people of age

years, who have Q17_CONGEN_DEFORMITI_HIP.

N-year risk Females Males
1 0.113% 0.388%
5 0.763% 2.236%
10 1.75% 5.465%
15 3.518% 10.243%
20 6.237% 17.495%

Relationships between endpoints

↥

Index endpoint: Q17_CONGEN_DEFORMITI_HIP – Congenital deformities of hip

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data